Lv1
18 积分 2025-05-13 加入
Implications of frequent hitter E3 ligases in targeted protein degradation screens
1天前
已完结
Design of PROTACs utilizing the E3 ligase GID4 for targeted protein degradation
1天前
已完结
Targeted protein degradation for cancer therapy
1天前
已完结
Induced proximity pushes beyond protein degraders, as first RIPTAC moves into the clinic
9天前
已完结
The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract Tumors
12天前
已完结
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial
13天前
已完结
Challenges for Chinese innovative cancer drugs in going global: insights from multiregional clinical trials
13天前
已完结
An allele-agnostic mutant-KRAS inhibitor suppresses tumor maintenance signals and reprograms tumor immunity in pancreatic cancer
13天前
已完结
Generation of actionable, cancer-specific neoantigens from KRAS(G12C) with adagrasib
15天前
已完结
Implementation of digital health technology in clinical trials: the 6R framework
16天前
已完结
皖公网安备34019202002308
